Zeposia, Vumerity Tie on Efficacy but Zeposia Has Superior Safety Profile
Findings presented at the 2023 Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS) were the first to compare the two drugs for relapsing-remitting multiple sclerosis.
Phase 2 Trial Drug Apitegromab Shows Progress for Spinal Muscular Atrophy Patients
The phase 2 TOPAZ trial demonstrated treatment is safe and improves motor function in patients with SMA.
2 Clarke Drive Cranbury, NJ 08512